eHIT leverages mobile technologies to enhance remote self-care services

eHIT Health GatewayeHIT Health Gateway platform offers a mobile solution to collect measurements directly from the measuring devices and seamlessly transfer the collected data to the healthcare personnel for further analysis. According to the type of monitoring instrument used, measured data are easily transferred to the patient's mobile device via Bluetooth, infrared or cable connection.

A single mobile device can collect, store and transfer information from different measuring devices. This also makes it possible to integrate devices from different manufacturers. For example, a blood pressure monitor, a weighing scale and a glucometer can be used to collect and register key information in diabetes care.

The patient can browse the results from a list or have them displayed in a clear graphical form directly on the screen of the mobile device. This gives the patients an immediate overview of the treatment progress.

Results are linked together and immediately forwarded by using GPRS, GSM or 3G technologies to the healthcare provider, where they are available for review. Following the analysis, the doctor or other healthcare professional can send feedback to the patient. As a result, patients not only remain informed about their health status via the information displayed on the mobile device, but can also quickly adapt their treatment, diet or exercise programme in response to the medical advice they receive from their healthcare provider.

The combination of self-monitoring devices with mobile technology presents several advantages in comparison with traditional monitoring methods. Remote measurement and monitoring is made possible regardless of a patient's location. Accurate measurement results are available in real time and in the required format. The patients' treatment can be monitored and quickly adapted to a change in health status as they can receive feedback regarding their treatment almost immediately. Furthermore, by being able to follow the progress of their treatment, patients are more motivated to comply with prescribed therapy. Additionally, evidence-based process traceability is provided.

For further information please contact:
eHIT Ltd
Microkatu 1
P.O. Box 1199
Kuopio 70211
Finland
http://www.ehit.fi
This email address is being protected from spambots. You need JavaScript enabled to view it.

Most Popular Now

AI Harnesses Tumor Genetics to Predict T…

In a groundbreaking study published on January 18, 2024, in Cancer Discovery, scientists at University of California San Diego School of Medicine leveraged a machine learning algorithm to tackle one...

Northern Care Alliance Deploys Digital P…

The trust's Oldham laboratory has completed technical go-live, with its Salford site also set to follow. Collectively the laboratories provide a wide range of general and specialist pathology services that...

American College of Radiology Releases J…

The American College of Radiology® (ACR®), working in close collaboration with four other radiology societies from around the world, have issued a joint statement on the development and use of...

Nine Tasks and One Big Challenge for Sha…

Opinion Article by Mark Hindle, vice president EMEA, Orion Health,. It's going to be a busy year in the shared care records space. NHS leaders, ShCRs and their suppliers are going...

Autonomous Synthesis Robot Uses AI to Sp…

Chemists of the University of Amsterdam (UvA) have developed an autonomous chemical synthesis robot with an integrated AI-driven machine learning unit. Dubbed 'RoboChem', the benchtop device can outperform a human...

AI in Personalized Cancer Medicine: New …

The application of AI in precision oncology has so far been largely confined to the development of new drugs and had only limited impact on the personalisation of therapies. New...

Paper Calls for Patient-First Regulation…

Ever wonder if the latest and greatest artificial intelligence (AI) tool you read about in the morning paper is going to save your life? A new study published in JAMA...

AI can Predict Brain Cancer Patients…

Artificial Intelligence (AI) can predict whether adult patients with brain cancer will survive more than eight months after receiving radiotherapy treatment. The use of the AI to successfully predict patient outcomes...

Max Planck Institute for Informatics and…

The Max Planck Institute for Informatics and Google deepen their strategic research partnership. With additional financial support from the U.S. IT company, the "Saarbrücken Research Center for Visual Computing, Interaction...

JMIR Medical Informatics Invites Submiss…

JMIR Publications has announced a new section titled, "AI Language Models in Health Care" in JMIR Medical Informatics. This leading peer-reviewed journal is indexed in PubMed and has a unique...

DMEA nova Award: Wanted - Visionary Solu…

9 - 11 April 2024, Berlin, Germany. The DMEA nova Award is being presented at DMEA 2024 for the first time. The award honours a digital health startup for an outstanding...

Could ChatGPT Help or Hurt Scientific Re…

Since its introduction to the public in November 2022, ChatGPT, an artificial intelligence system, has substantially grown in use, creating written stories, graphics, art and more with just a short...